PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week ' s topics include a biomarker for Parkinson ' s disease, therapy for blood clots after casting or knee arthroscopy, avoiding sickle cell crises, and CABG versus stenting. (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - December 10, 2016 Category: Surgery Source Type: news

Medtronic wins expanded CE Mark indication for Endurant II stent graft
Medtronic (NYSE:MDT) said today that it won an expanded CE Mark indication in the European Union for its Endurant II/IIs stent graft for treating abdominal aortic aneurysms. The expanded indication covers a new endovascular implantation approach using a parallel graft chimney approach called ChEVAR, which allows the device to be used to treat aneurysms with an aortic neck length of 2mm or more. Aortic neck length is the distance from the renal arteries to the aneurysm. The ChEVAR approach, which uses balloon-expandable covered stents in the renal arteries and a stent graft in the aorta, is designed to increase the infraren...
Source: Mass Device - December 6, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Regulatory/Compliance Stent Grafts Medtronic Source Type: news

Invendo Medical wins CE Mark for Invendoscope SC200
Invendo Medical said today it won CE Mark approval in the European Union for its Invendoscope SC200, which it touts as the world’s 1st sterile, single-use colonoscope. The German company said its device is designed to eliminate the complex reprocessing of endoscopes that create a serious risk of cross-contamination and the culturing of resistant bacteria. “Our revolutionary technology uniquely addresses the significant challenges associated with the cleaning and disinfecting of traditional reusable endoscopes by providing an ergonomically advanced endoscope that offers both sterility and single use. The CE Ma...
Source: Mass Device - December 5, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Endoscopic / Arthroscopic Regulatory/Compliance Invendo Medical Source Type: news

Low-Molecular-Weight Heparin Doesn't Prevent VTE After Knee Arthroscopy or Leg Casting (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Andr é Sofair, MD, MPH Low-molecular-weight heparin doesn ' t seem to prevent symptomatic venous thromboembolism (VTE) in patients undergoing knee arthroscopy or lower leg casting, suggest two trials in the New England Journal of … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 4, 2016 Category: Primary Care Source Type: news

Level of evidence of free papers presented at the European Society of Sports Traumatology, Knee Surgery and Arthroscopy congress from 2008 to 2016 - Kay J, Memon M, Rogozinsky J, Simunovic N, Seil R, Karlsson J, Ayeni OR.
PURPOSE: The European Society of Sports Traumatology, Knee Surgery and Arthroscopy (ESSKA) congress is an important venue, and the research presented can be a critical source of information used to impact clinical decisions and health policies. The purpose... (Source: SafetyLit)
Source: SafetyLit - December 3, 2016 Category: Global & Universal Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news

Young adults are suffering from 'old age conditions' more than ever before because they watch too much TV
Arthroscopic knee operations, where surgeons look inside the joint to figure out what's causing the pain, were one of the most popular in British 36 to 45 year olds, researchers found. (Source: the Mail online | Health)
Source: the Mail online | Health - November 25, 2016 Category: Consumer Health News Source Type: news

Boston Scientific closes $210m EndoChoice buy
Boston Scientific (NYSE:BSX) said today that it closed its $210 million buyout of EndoChoice (NYSE:GI) and its line of devices for treating gastrointestinal disease. The $8-per-share tender offer was originally slated to expire at midnight Nov. 4. Marlborough, Mass.-based Boston Scientific later moved the deadline out to Nov. 21. they  September. Alpharetta, Ga.-based EndoChoice took itself public in June 2015 with an IPO that brought in some $96 million. “We are excited to provide physicians more comprehensive solutions to help assess, diagnose and treat patients with GI conditions,” endoscopy president...
Source: Mass Device - November 22, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Mergers & Acquisitions Wall Street Beat Boston Scientific EndoChoice Source Type: news

Integrated Endoscopy names Sharp as prez & CEO | Personnel Moves November 15, 2016
Integrated Endoscopy said today it tapped Brad Sharp as its new prez & CEO, as well as joining the company’s board. The company said it is making the move with Sharp in preparation of the launch of its Nevis single-use arthroscope, which is slated for early 2017. The company said it also named Rob Cripe as global marketing exec VP, Laxmi Khanolkar as Asia/Middle East sales VP, Mike Amell as manufacturing VP and Tom Colonna as regulatory affairs and quality assurance VP. “We are fortunate to have Brad Sharp join and lead the Integrated Endoscopy team. Brad has laid out a new vision for the company, which include...
Source: Mass Device - November 15, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Ancora Heart Beaver-Visitec Cynosure Inc. Integrated Endoscopy Personnel Moves RoundTable Healthcare Partners Stentys Source Type: news

Integrated Endoscopy Significantly Expands Management Team in Advance of U.S. Product Launch
RANCHO SANTA MARGARITA, Calif.--(Healthcare Sales & Marketing Network)--Integrated Endoscopy, Inc., today announced the appointment of Brad Sharp as President, Chief Executive Officer, and member of the board of directors in preparation for a global commer... Devices, Orthopaedic, Personnel Integrated Endoscopy, Nuvis , Single-Use Arthroscope (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 15, 2016 Category: Pharmaceuticals Source Type: news

The 9 Sneaky Things That Are Causing Your Knee Pain
SPECIAL FROM Next Avenue Whether it came on suddenly when you were playing tennis or more gradually over many years, knee pain can keep you from doing even the most basic of activities. At the very least, it can limit your ability to move as easily or quickly, or sit in one place for an extended time.   Arthritis is the most common cause of knee pain for older adults, said Dr. Julie Switzer, an orthopedic surgeon at Regions Hospital in St. Paul, Minn. Arthritis comes in three main forms, she said: osteoarthritis, inflammatory arthritis and post-traumatic arthritis. We’ll examine these types, as well as other...
Source: Healthy Living - The Huffington Post - November 15, 2016 Category: Consumer Health News Source Type: news

Snapping Scapula Syndrome
What is snapping scapula syndrome? Snapping scapula syndrome is a condition causing painful grinding, clicking or snapping of the shoulder blade (Figure 1). The shoulder joint itself is called the glenohumeral joint. The acromioclavicular joint is associated with shoulder separation. Snapping scapula occurs at the scapulothoracic joint and is different from other shoulder related problems (Figure 2). Over 1/3 of the shoulder movement occurs between the scapula and the thoracic cage. The shoulder blade serves as an anchor for the subscapularis and serratus anterior muscles (Figure 3). These muscles as well as the...
Source: Healthy Living - The Huffington Post - November 10, 2016 Category: Consumer Health News Source Type: news

Preoperative and postoperative serial assessments of postural balance and fall risk in patients with arthroscopic anterior cruciate ligament reconstruction - Gokalp O, Akkaya S, Akkaya N, B üker N, Gungor HR, Ok N, Yorukoglu C.
BACKGROUND: Impaired postural balance due to somatosensory data loss with mechanical instability has been shown in patients with ACL deficiency. OBJECTIVE: To assess postural balance in patients with ACL insufficiency prior to surgery and following... (Source: SafetyLit)
Source: SafetyLit - November 5, 2016 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Boston Scientific extends $210 million tender offer for EndoChoice
Boston Scientific (NYSE:BSX) said today that it’s extending its $210 million tender offer for EndoChoice (NYSE:GI) and its line of devices for treating gastrointestinal disease. The $8-per-share tender offer was slated to expire at midnight Nov. 4. Marlborough, Mass.-based Boston Scientific said it’s moving the deadline out to Nov. 21 “to allow additional time for the satisfaction of the conditions of the offer.” Some 66.5% of outstanding EndoChoice shares had been tendered as of yesterday, the company said. When the tender launched Oct. 7, EndoChoice directors, affiliated funds and other stockh...
Source: Mass Device - November 4, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Mergers & Acquisitions Wall Street Beat Boston Scientific EndoChoice Source Type: news

Swiss researchers develop material that goes highly flexible to rigid
Researchers from Switzerland’s École Polytechnique Fédérale de Lausanne (EPFL) have developed a composite material made from silicone and copper alloy that can morph from being highly flexible to rigid as its temperature varies. The team says the tube’s flexibility could be useful in endoscopic procedures, where anatomy presents a challenge for rigid devices to maneuver within the body. And when it comes time for the instrument to take a biopsy, the tube can become rigid. Get the full story at our sister site, Medical Design & Outsourcing. The post Swiss researchers develop material that goes highly f...
Source: Mass Device - November 4, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Endoscopic / Arthroscopic Materials Testing Robotics École Polytechnique Fédérale de Lausanne Source Type: news

Boston Scientific buys LumenR ’ s tissue retractor
Boston Scientific (NYSE:BSX) said today that it paid an unspecified amount for a tissue retractor developed by LumenR for endoscopic resection of the gastrointestinal tract. The Newark, Calif.-based company’s device is designed to improve endoscopic sub-mucosal dissection and mucosal resection procedures to remove pre-cancerous lesions and malignant tumors in the colon, esophagus and stomach. The LumenR device also features what Boston Scientific called “enhanced visualization” of GI tract lesions. “We are excited about the potential of the LumenR system to improve visibility and control during...
Source: Mass Device - November 3, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Mergers & Acquisitions Wall Street Beat Boston Scientific LumenR Source Type: news